1st Quarter - Report
ROCK & ASSOCIATES for DIAMONDBACK DRUGS
Firm
Client
Income
$11,250
Expenses
—
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Legislation pertaining to pharmacy compounding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK | — |
Budget/Appropriations BUD
Appropriations for FDA for FY2017 and FY2018
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK | — |
Pharmacy PHA
Legislation pertaining to pharmacy compounding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK | — |
Law Enforcement/Crime/Criminal Justice LAW
Controlled substance issues pertaining to pharmacy compounding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.